Will BMJ Study Linking EU-First Innovations With More Safety Alerts Prompt Tougher UK Regs?
This article was originally published in Clinica
Executive Summary
Findings from a new study which link a much higher rate of safety alerts with innovative devices that are approved first in the EU before going through the US FDA has been picked up by UK Brexit supporters as evidence of Brussels’ failure to regulate devices.